Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
3.
J Med Primatol ; 42(3): 105-11, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23398349

ABSTRACT

BACKGROUND: Olfactomedin-like is a family of polyfunctional polymeric glycoproteins. This family has at least four members. One member of this family is OLFML3, which is preferentially expressed in placenta but is also detected in other adult tissues including the liver and heart. However, its orthologous rat gene is expressed in the iris, sclera, trabecular meshwork, retina, and optic nerve. METHODS: OLFML3 messenger amplification was performed by RT-PCR from human and baboon ocular tissues. The products were cloned and sequenced. RESULTS: We report OLFML3 expression in human and baboon eye. The full coding DNA sequence has 1221 bp, from which an open reading frame of 406 amino acid was obtained. The baboon OLFML3 gene nucleotidic sequence has 98% and amino acidic 99% similarity with humans. CONCLUSIONS: OLFML3 gene expression in human and baboon ocular tissues and its high similarity make the baboon a powerful model to deduce the physiological and/or metabolic function of this protein in the eye.


Subject(s)
Eye/metabolism , Glycoproteins/genetics , Papio hamadryas/genetics , Adolescent , Aged , Aged, 80 and over , Amino Acid Sequence , Animals , Child , Cloning, Molecular , DNA, Complementary/genetics , DNA, Complementary/metabolism , Glycoproteins/metabolism , Humans , Male , Middle Aged , Molecular Sequence Data , Organ Specificity , Papio hamadryas/metabolism , Polymerase Chain Reaction , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Alignment , Spain
4.
Am J Ophthalmol ; 100(2): 293-8, 1985 Aug 15.
Article in English | MEDLINE | ID: mdl-4025470

ABSTRACT

Six patients (five men and one woman, 19 to 57 years old) with laboratory-proven fungal corneal infections were successfully treated with topical ketoconazole, a synthetic imidazole derivative. No signs of progression of the corneal infection were seen after the antifungal therapy was initiated. The clinical signs of corneal infection disappeared after three (Aspergillus infections) to seven weeks (Fusarium infections) of ketoconazole therapy. In all cases, posttreatment visual acuities were better than pretreatment visual acuities. No significant biomicroscopic signs of ocular surface toxicity were noted.


Subject(s)
Aspergillosis/drug therapy , Keratitis/drug therapy , Ketoconazole/therapeutic use , Mycoses/drug therapy , Administration, Topical , Adult , Aspergillosis/physiopathology , Female , Fusarium , Humans , Keratitis/physiopathology , Ketoconazole/administration & dosage , Male , Middle Aged , Mycoses/physiopathology , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...